ES2192035T3 - Agentes anti-inflamatorios que presentan una selectividad para los glucocorticoides. - Google Patents

Agentes anti-inflamatorios que presentan una selectividad para los glucocorticoides.

Info

Publication number
ES2192035T3
ES2192035T3 ES99906996T ES99906996T ES2192035T3 ES 2192035 T3 ES2192035 T3 ES 2192035T3 ES 99906996 T ES99906996 T ES 99906996T ES 99906996 T ES99906996 T ES 99906996T ES 2192035 T3 ES2192035 T3 ES 2192035T3
Authority
ES
Spain
Prior art keywords
glucocorticoids
selectivity
present
inflammatory agents
autoimmune diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99906996T
Other languages
English (en)
Inventor
Michael J Coughlan
Steven W Elmore
Michael E Kort
Philip R Kym
Jimmie L Moore
John K Pratt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Ligand Pharmaceuticals Inc
Original Assignee
Abbott Laboratories
Ligand Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories, Ligand Pharmaceuticals Inc filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2192035T3 publication Critical patent/ES2192035T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Agentes anti-inflamatorios que presentan una selectividad para los glucocorticoides. La presente invención se refiere a benzopirano[3, 4- f ] quinolinas selectivas del receptor de glucocorticoides que son útiles para tratar enfermedades inmunes o autoinmunes, a las composiciones farmacéuticas que comprenden estos compuestos, y a los métodos para inhibir la inflamación, las enfermedades inflamatorias, y las enfermedades inmunes y autoinmunes en mamíferos.
ES99906996T 1998-02-13 1999-02-12 Agentes anti-inflamatorios que presentan una selectividad para los glucocorticoides. Expired - Lifetime ES2192035T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10

Publications (1)

Publication Number Publication Date
ES2192035T3 true ES2192035T3 (es) 2003-09-16

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99906996T Expired - Lifetime ES2192035T3 (es) 1998-02-13 1999-02-12 Agentes anti-inflamatorios que presentan una selectividad para los glucocorticoides.

Country Status (21)

Country Link
EP (1) EP1053239B1 (es)
JP (1) JP2002503665A (es)
KR (1) KR20010040935A (es)
CN (1) CN1119348C (es)
AT (1) ATE230749T1 (es)
AU (1) AU766441B2 (es)
BG (1) BG64317B1 (es)
BR (1) BR9907788A (es)
CA (1) CA2320943A1 (es)
DE (1) DE69904804T2 (es)
DK (1) DK1053239T3 (es)
ES (1) ES2192035T3 (es)
HK (1) HK1033308A1 (es)
HU (1) HUP0100460A3 (es)
IL (1) IL137508A0 (es)
NO (1) NO20004053L (es)
NZ (1) NZ506013A (es)
PL (1) PL193323B1 (es)
SK (1) SK284689B6 (es)
TR (1) TR200003094T2 (es)
WO (1) WO1999041256A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6593480B2 (en) * 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
EP1201660B1 (en) 2000-10-30 2005-08-31 Pfizer Products Inc. Glucocorticoid receptor modulators
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) * 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
AU2003202216A1 (en) 2002-01-14 2003-07-30 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
EP1490317A1 (en) 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DK1490062T3 (da) 2002-03-26 2008-04-28 Boehringer Ingelheim Pharma Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf
WO2003086294A2 (en) 2002-04-11 2003-10-23 Merck & Co., Inc. 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US6858627B2 (en) 2002-08-21 2005-02-22 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CL2003001544A1 (es) * 2002-10-11 2005-01-07 Ligand Pharm Inc Compuestos derivados de 5-cicloalquenil-5h-cromeno[3,4-f]quinolina de formula i, moduladores selectivos del receptor de progesterona; composicion farmaceutica; y su uso en el tratamiento de sangrado uterino disfuncional, dismenorrea, endometriosis, l
DE20301728U1 (de) * 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
AR040783A1 (es) * 2002-10-11 2005-04-20 Ligand Pharm Inc 5-(1',1'-cicloaquil/alquenil) metiliden-1,2 -dihidro-5-h-cromeno [3,4- f] quiinolinas como compuestos moduladores selectivos de receptores de progesterona
WO2004063163A1 (en) 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
WO2005040145A1 (en) 2003-10-16 2005-05-06 Boehringer Ingelheim Pharmaceuticals, Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
JP2008525525A (ja) 2004-12-27 2008-07-17 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物及び使用
CA2621292C (en) * 2005-09-14 2014-05-27 Santen Pharmaceutical Co., Ltd. 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
TW201111392A (en) 2009-06-16 2011-04-01 Schering Corp Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
CA2769563A1 (en) 2009-07-31 2011-02-10 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1382597A3 (en) * 1994-12-22 2004-04-07 Ligand Pharmaceuticals, Inc. Steroid receptor modulator compounds and methods

Also Published As

Publication number Publication date
NZ506013A (en) 2003-03-28
ATE230749T1 (de) 2003-01-15
BG64317B1 (bg) 2004-09-30
CN1119348C (zh) 2003-08-27
DK1053239T3 (da) 2003-04-22
EP1053239A1 (en) 2000-11-22
KR20010040935A (ko) 2001-05-15
JP2002503665A (ja) 2002-02-05
HK1033308A1 (en) 2001-08-24
CN1296486A (zh) 2001-05-23
EP1053239B1 (en) 2003-01-08
WO1999041256A1 (en) 1999-08-19
PL343018A1 (en) 2001-07-30
HUP0100460A3 (en) 2003-03-28
DE69904804T2 (de) 2003-11-06
BG104719A (en) 2001-05-31
BR9907788A (pt) 2001-10-30
HUP0100460A2 (hu) 2001-09-28
AU766441B2 (en) 2003-10-16
NO20004053D0 (no) 2000-08-11
NO20004053L (no) 2000-09-11
SK11972000A3 (sk) 2001-08-06
PL193323B1 (pl) 2007-02-28
AU2677399A (en) 1999-08-30
SK284689B6 (sk) 2005-09-08
DE69904804D1 (de) 2003-02-13
TR200003094T2 (tr) 2001-01-22
CA2320943A1 (en) 1999-09-19
IL137508A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ES2192035T3 (es) Agentes anti-inflamatorios que presentan una selectividad para los glucocorticoides.
UY26058A1 (es) Compuestos utiles como antiinflamatorios ley 17.164 art. 127
UY26817A1 (es) Agentes antiinflamatorios selectivos de glucocorticoides
ES2191320T3 (es) Derivados de piperazina y su uso como agentes anti-inflamatorios.
PT1053240E (pt) Agentes anti-inflamatorios selectivos para glucocorticoides
ES2183937T3 (es) Inhibidores de la adhesion celular.
NO965516L (no) Sterolderivater anvendt til regulering av meiose
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
BR9609738A (pt) Composições para aplicação de droga para estabilidade melhorada de esteróides
IS5985A (is) Frumuviðloðunar-bælandi bólgu-eyðandi og ónæmisbælandi efnasambönd
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
DE69838882D1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
PA8467301A1 (es) Nuevos derivados del acido dihidroxihexanoico
BR9608594B1 (pt) misturas de benzimidazóis substituìdos para o combate de protozoários parasìticos.
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
DE69407057T2 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ECSP951367A (es) Derivados tetraciclicos procesos para su preparacion y su uso
ES2167942T3 (es) Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes.
ECSP003382A (es) Compuestos utiles como antiinflamatorios
MX9101926A (es) Tetrahidropiridinas e hidroxipiperidinas substituidas como agentes del sistema nervioso central.
ECSP003751A (es) Nuevos compuestos
MX9302324A (es) Antagonistas de endotelina ii.